Nobel Prize Recognizes Pioneering Body's Defenses Discoveries
The Nobel Prize in medical science was awarded for transformative discoveries that clarify how the immune system targets harmful pathogens while sparing the body's own cells.
Three renowned scientists—Japan's Prof. Sakaguchi and US experts Dr. Brunkow and Fred Ramsdell—received this honor.
The research identified specialized "sentinels" within the defense system that eliminate rogue defense cells capable of attacking the body.
These discoveries are now enabling innovative therapies for autoimmune diseases and cancer.
These laureates will divide a monetary award worth 11m SEK.
Decisive Discoveries
"The research has been essential for comprehending how the immune system functions and why we do not all develop severe self-attack conditions," commented the chair of the Nobel Committee.
This team's studies address a core question: How does the immune system defend us from countless infections while keeping our own tissues intact?
The immune system uses immune cells that scan for signs of infection, including viruses and bacteria it has never encountered.
These cells employ detectors—called recognition units—that are produced by chance in a vast number of combinations.
That provides the immune system the ability to combat a wide array of threats, but the unpredictability of the mechanism unavoidably produces white blood cells that may target the body.
Security Guards of the Body
Scientists earlier understood that a portion of these problematic defense cells were destroyed in the thymus—the site where white blood cells mature.
This year's Nobel Prize recognizes the discovery of regulatory T-cells—described as the immune system's "security guards"—which patrol the system to disarm other immune cells that attack the healthy cells.
It is known that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and RA.
A Nobel panel added, "These findings have established a novel area of investigation and spurred the creation of new therapies, for example for cancer and autoimmune diseases."
Regarding malignancies, T-regs block the system from fighting the growth, so studies are aimed at lowering their quantity.
For autoimmune diseases, experiments are testing increasing regulatory T-cells so the body is not being harmed. A similar approach could also be effective in minimizing the chances of transplanted organ rejection.
Pioneering Studies
Professor Sakaguchi, of Osaka University, conducted experiments on rodents that had their immune gland extracted, causing autoimmune disease.
The researcher demonstrated that injecting immune cells from healthy animals could prevent the disease—implying there was a system for blocking defenders from harming the body.
Mary Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were studying an inherited immune disorder in mice and people that led to the discovery of a gene vital for how regulatory T-cells operate.
"Their pioneering research has uncovered how the body's defenses is controlled by T-reg cells, stopping it from mistakenly attacking the body's own tissues," commented a leading physiology specialist.
"The research is a remarkable illustration of how fundamental physiological study can have broad implications for public health."
